Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

NCT00001059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Doxorubicin hydrochloride (liposomal)
DRUG: Filgrastim
DRUG: Bleomycin sulfate
DRUG: Vincristine sulfate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]